Abstract:Objective:To explore the pathological change and expressions of Survivin and caspase- 3 in villi in women with different gestational ages.Methods:Sixty specimens were collected from women seeking for termination of early pregnancy in Department of Gynecology and Obstetrics of The General Hospital of Tianjin Medical University between May 1,2011 and June30,2011.Thirty women with 40 to 49 days of gestational ages were randomly divided into two groups(control group A and study group A),and the other 30 women with 50 to 63 days of gestational ages were randomly divided into two groups(control group B and study group B).Women in the study group were treated with 150 microgram mifepristone before artificial abortion with suction evacuation.The villus tissue was collected.The pathological change of villus was evaluated with a light microscope and expression levels of Survivin and caspase- 3 in villi were detected by immunohistochemistry technique.Results:In study groups,proliferation nodules of trophoblastic cells were significantly reduced(P <0.05).There were no significant differences in the number of proliferation nodules of trophoblastic cells between control A and B groups as well as study A and B groups(P both >0.05).Expressions of Survivin were observed in the nucleus and cytoplasm of the villi in the controlgroup and the study group.The expression level of Survivin was lower in the study group(P<0.05).There were no significant differences in expression level of Survivin between control A and B groups as well as study A and B groups(P both >0.05).Expressions of caspase-3 were observed in the cytoplasm of the villi in the control group and the study group.The expression level of caspase-3 was lower in the control group(P<0.05).There were no significant differences in expression level of caspase-3 between control A and B groups as well as study A and B groups(P both >0.05).Conclusion:Mifepristone could inhibit the formation of proliferation nodules of trophoblastic cells.And the mifepristone could inhibit the expression of Survivin and improve that of caspase-3,resulting in termination of early pregnancy due to the promotion of apoptosis.It can be suggested that there is the same effect of 150 microgram mifepristone on medical abortion for different gestational ages of early pregnaney.

Clinical Study of Terminating Early Pregnancy with Mifepristone

Clinical Study of Termination of Early Pregnancy in 7-9 Weeks Gestation

Analysis of Mifeprestone Combine Misoprostol Induced Early Pregnancy Ending after Cesarean Section

Clinical Study on Termination of Early Pregnancy Less Than 7 Gestational Weeks by Compound Mifepristone

The Retrospective Analysis on the Influence of Taking Mifepristone and Misoprostol During First-trimester Pregnancy and Its Following Impact on Tissue Residual After Induced Abortion

Investigation of the 12-Month Efficacy and Safety of Low-Dose Mifepristone in the Treatment of Painful Adenomyosis

Clinical Effect of Three Different Methods in Termination of Midtrimester Pregnancy

Mifepristone Combined with Misoprostol Versus Intra-Amniotic Injection of Ethacridine Lactate for the Termination of Second Trimester Pregnancy: a Prospective, Open-Label, Randomized Clinical Trial

Preliminary study on the effect of mifepristone followed by diffferent regimens of misoprostol for termination of pregnancy between 8 and 16 weeks of gestation

Meta-analysis of Clinical Effects in Early Pregnancy Termination after Compound Mifepristone and Misoprostol

The Efficacy and Influence Factors Analysis of Mifepristone Combined with Estrogen-Progesterone in the Treatment of Incomplete Abortion

The Application of Mifepristone Complicated Misoprostol for the Termination of Pregnancy with 12～14 Gestational Weeks in the Embryulcia Surgery

Clinical Study on Mifepristone for Shortening the Time of Vaginal Bleeding after Drug Induced Abortion

The effectiveness of different methods in termination of second trimester pregnancy

Study on the Effects of Mifepristone and Misoprostol to Terminate the Medium-Term Pregnancy

Effect of Different Dosages and Administering Approaches on Early Medical Abortion

Mifepristone in Combination with Misoprostol for the Termination of Pregnancy at 8–16 Weeks' Gestational Age: A Multicentre Randomized Controlled Trial

Different intervals of misoprostol administration for termination of second trimester pregnancy:a randomized controlled trail

Effects of mifepristone on structure and expressions of Survivin and caspase-3 in villi in women with different gestational ages

Probe into the Effect of Mifepristone on Angiogenesis of Human Chorionic Villi and Decidual Cells

One- and two-day mifepristone–misoprostol intervals for second trimester termination of pregnancy between 13 and 16weeks of gestation